PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentIVF and the prevention of mitochondrial DNA disease: the moral issues

BioNews

IVF and the prevention of mitochondrial DNA disease: the moral issues

Published 31 October 2012 posted in Comment and appears in BioNews 605

Author

Professor Alison Murdoch

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).

Medicine has faced many controversial milestones, none more so than those involving reproduction. The UK Government must now decide whether we can use IVF technology to reduce the risk of transmission of mitochondrial DNA abnormalities. Will they accept it or reject it?...

'And since it is always more agreeable to think in simple than in complicated terms, and since moral indignation is one of the most delightful of passions to indulge in, I believe that there is a real danger that the indignant will win the day and all research using human embryos will be brought to an end. Those who believe in the need for this research have a duty to argue their case as widely, but also as intelligently, as possible' Mary Warnock, 1985 (1).

Medicine has faced many controversial milestones, none more so than those involving reproduction. IVF was one but, after 30 years, it is now accepted medical practice enabling previously infertile couples to become parents. IVF has also evolved to help couples with other problems. For example, PGD (preimplantation genetic diagnosis) enables those who carry a serious risk of having a child with cystic fibrosis to transfer an embryo without that genetic fault.

Technology has developed in other areas too, such as reproductive cloning. However, this has been agreed internationally to be a step too far and is prohibited in humans. The UK Government must now decide whether we can use IVF technology to reduce the risk of transmission of mitochondrial DNA abnormalities. Will they accept it or reject it?

The UK's Secretary of State has before him a report on the scientific progress towards finding techniques that will reduce the risk of a mother transmitting abnormal mitochondria to her children (2). We now have a clear plan, with a foreseeable timescale, for the implementation of these techniques. Government approval is required to permit this treatment.

The new techniques will help a woman who carries abnormal mitochondrial DNA to have a healthy baby. The nuclear DNA of her embryo (carrying the information that determines her baby's characteristics) will be transferred to an activated, enucleated egg of a donor with normal mitochondrial DNA.

Although the scientific path is clear, the moral issues are undefined. Three main issues emerge. First, are we stepping over an acceptable line by manipulating embryos? Second, are techniques acceptable if the results will be passed to the next generation? Finally, is it right for society to deny treatment because of these concerns?

Routine IVF treatment creates more embryos than will be transferred. They have been knowingly created to increase the chance that at least one will result in a baby. 'Using' embryos in this way is accepted practice. 'Disrupting' embryos (e.g. taking a biopsy for PGD) is also a routine procedure. Although challenged by some, in these respects the proposed techniques are not new.

When we use IVF to prevent mitochondrial DNA disease, we will also have transplanted intracellular structures from egg donor to child. Is this really novel? A child who has had a bone marrow transplant will be healthy because cells from another person are integrated into their body; they have genetic material originating from three people. This may be argued to be an issue of scale, not one of fundamental moral concern.

Some will argue changes to a baby's mitochondrial DNA are different because the change will pass to the next generation. This is termed 'germ line therapy', a technological Rubicon. Changes in the nuclear DNA would be passed through the germ line - sperm and eggs - to the next generation. By association, we need to consider eugenics, if only to dismiss it.

Modification of the nuclear DNA in human embryos is illegal in the UK. Breaking the inheritance chain is currently achieved by selecting healthy embryos for transfer, for example, PGD or abortion after prenatal diagnosis. Although permitted in the UK, both have been challenged because of the risk that they promote the philosophy of eugenics.

Mitochondrial DNA is passed intact down the maternal line and does not influence a person's characteristics, despite affecting their heath. While not underestimating the issues, they mainly arise by similarity of terminology not intent. Like PGD, preventing mitochondrial DNA disease falls within the good medical practice of preventing serious illness, not eugenics.

The most difficult ethical issues are those faced by the potential parents of children, not politicians making the decisions to permit these techniques. Parents must live with the consequences of giving birth to a child with serious disability, using donated gametes, having no children or risking this new technique. When debating the issues above, we must consider the patients living with these real dilemmas. Society is not harmed by these techniques, neither are any other people within society.

The use of sensational or exaggerated comments in this debate is irresponsible. Similar discussions before IVF resulted in unwarranted social stigmatisation of early IVF babies. The family that take home a baby that has been 'cured before implantation' or even 'cured before conception' will inevitably receive attention, but responsible terminology and debate now may reduce future stigmatisation.

Their child will contain genetic material from more than its mum and dad. They may be labelled 'miracle babies', but to mum and dad they will just be their own healthy baby. Where is the moral right in denying them that choice?

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
22 July 2013 • 5 minutes read

How worried should we be about the 'slippery slope to designer babies'?

by Professor Stephen Wilkinson

Why are potentially positive developments like mitochondrial replacement therapy and next-generation sequencing greeted with talk of 'designer babies', and is such language justified?

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
10 April 2013 • 2 minutes read

Mitochondria in the spotlight

by Sarah Norcross

Mitochondria don't normally get much press attention, they like to keep a low profile generating energy in the cells and leave nuclear DNA to grab the headlines...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
18 February 2013 • 5 minutes read

Policing preimplantation genetic diagnosis: patients first please

by Professor Alan Handyside and 3 others

The Human Fertilisation and Embryology Authority recently announced plans to review the list of approved inherited conditions for which preimplantation genetic diagnosis is currently licensed to ensure that it is only available for conditions which meet the statutory requirements in the UK...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
30 January 2013 • 4 minutes read

Beyond the treatment of infertility

by Professor Mary Herbert

The advent of PGD extended the scope of IVF beyond the treatment of infertility. PGD is predominantly used to prevent transmission of genetic defects arising from mutations in nuclear DNA. However, it can also be used to reduce the risk of transmitting mutations in mitochondrial DNA (mtDNA), which cause a range of debilitating and life-threatening diseases...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
30 January 2013 • 3 minutes read

Why we should back a law change to allow mitochondrial transfer into the clinic

by Dr Kristina Elvidge

Mitochondrial diseases are soon to be brought to the attention of the general public, as the Government seeks to gauge the attitude of the nation towards a ground-breaking IVF treatment that could prevent these conditions being passed from mother to child...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Gamete Donation Review - not the HFEA's finest hour

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 4 minutes read

Why the UK should extend the 14-day rule to 28 days

25 July 2022 • 5 minutes read

200 Years of Mendel: From Peas to Personalised Medicine

8 August 2022 • 4 minutes read

Citizenship and same-sex parents – about time, Sweden!

8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 4 minutes read

Why the UK should extend the 14-day rule to 28 days

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856